
    
      The objective of this study is to evaluate the long-term safety of the PRESERFLOÂ® MicroShunt
      in subjects with Primary Open-Angle Glaucoma who have completed their Month 24 Follow-Up
      Visit in the INN-005 clinical study, by collecting safety data through 5 years post-operative
      follow-up.
    
  